Stephen S. Nigh
Expertise in
14
conditions

Dr. Stephen S. Nigh

Radiation Oncology
800 W. Central Rd., Oncology Department, 
Arlington Heights, IL 
Accepting New Patients
Referral may be required
Before you request
Expertise in
14
conditions
800 W. Central Rd., Oncology Department, 
Arlington Heights, IL 

Overview

Stephen Nigh is a Radiation Oncologist practicing medicine in Arlington Heights, Illinois.

Dr. Nigh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor.

Dr. Nigh is board certified in American Board Of Radiology. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Nigh is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in IL

Board Certifications

American Board Of Radiology

Hospital Affiliations

Northwest Community Hospital 1

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Radiation Oncology Associates, LLC
800 W. Central Rd., Oncology Department, Arlington Heights, IL 60005

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Enrollment Status: Completed
Publish Date: June 26, 2026
Intervention Type: Procedure
Study Phase: Phase 3
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Radiation
Study Phase: Phase 1
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Radiation, Drug
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Enrollment Status: Unknown
Publish Date: May 24, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: mFOLFIRINOX, FOLFOX
Study Phase: Phase 2
View 7 Less Clinical Trials

1 Total Publications

Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study.
Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study.
Journal: Brachytherapy
Published: May 13, 2016
Similar Doctors
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Referral may be required
Before you request

Northwestern Medicine Cancer Center Warrenville

4405 Weaver Pkwy, 
Warrenville, IL 
 (20.1 miles away)
Experience:
19+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vinai Gondi is a Radiation Oncologist practicing medicine in Warrenville, Illinois. He has been practicing medicine for over 19 years. Dr. Gondi is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Astrocytoma, Glioblastoma, Glioma, and Gamma Knife Radiosurgery. Dr. Gondi is board certified in American Board Of Radiology - Radiation Oncology (Certified). Dr. Gondi is currently accepting new patients.

Expertise in
2
conditions
Dr. Parthiv S. Mehta
Radiation Oncology
Expertise in
2
conditions
Dr. Parthiv S. Mehta
Radiation Oncology
Referral may be required

UroPartners Cancer Treatment Center Glenview

2600 Patriot Blvd Unit J, 
Glenview, IL 
 (8.1 miles away)
224-260-3100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Parthiv Mehta is a Radiation Oncologist practicing medicine in Glenview, Illinois. Dr. Mehta is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer and Familial Prostate Cancer. Dr. Mehta is currently accepting new patients.

Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (27.6 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stanley Liauw is a Radiation Oncologist practicing medicine in Chicago, Illinois. Dr. Liauw is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Prostatectomy, and Nephrectomy. Dr. Liauw is board certified in Practicing Since2006 and Radiation Oncology. Dr. Liauw is currently accepting new patients.

Frequently Asked Questions about Dr. Stephen S. Nigh

How do I make an appointment with Dr. Stephen S. Nigh?

You can book an appointment with Dr. Stephen S. Nigh by calling their office at 847-618-6560. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stephen S. Nigh a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stephen S. Nigh is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stephen S. Nigh specialize in?

While Dr. Stephen S. Nigh is a Radiation Oncology, they have specific expertise in Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Stephen S. Nigh participate in research or clinical trials?

Yes. Dr. Stephen S. Nigh has published 1 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Stephen S. Nigh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stephen S. Nigh accept my insurance?

Dr. Stephen S. Nigh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-618-6560 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nigh's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 56 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile